In addition to clinical characteristics, biomarkers shown to improve bleeding and/or stroke risk estimates are also part of the clinical scores, such as NT-proBNP, high-sensitivity cardiac troponin T (hsTnT), growth differentiation factor-15 (GDF-15), hemoglobin level and platelet count [6,9]. Here, GDF15 is linked to stroke disorder.